ScoreWhy is Biogened SA ?
1
The company is Net-Debt Free
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 8.84% signifying low profitability per unit of shareholders funds
2
High Debt company with Weak Long Term Fundamental Strength
3
Positive results in Jun 26
- OPERATING CASH FLOW(Y) Highest at PLN 12.91 MM
- RAW MATERIAL COST(Y) Fallen by -8.78% (YoY)
- NET PROFIT(9M) Higher at PLN 4.8 MM
4
With ROE of 10.30%, it has a very attractive valuation with a 0.96 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -30.00%, its profits have risen by 1.9% ; the PEG ratio of the company is 4.9
5
Below par performance in long term as well as near term
- Along with generating -30.00% returns in the last 1 year, the stock has also underperformed Poland WIG in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Biogened SA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Biogened SA for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Biogened SA
-26.87%
-0.02
56.95%
Poland WIG
37.09%
2.22
16.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
17.18%
EBIT Growth (5y)
24.18%
EBIT to Interest (avg)
5.13
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0.40
Sales to Capital Employed (avg)
1.71
Tax Ratio
33.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.31%
ROE (avg)
8.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.96
EV to EBIT
6.73
EV to EBITDA
4.53
EV to Capital Employed
0.97
EV to Sales
0.58
PEG Ratio
4.93
Dividend Yield
135.87%
ROCE (Latest)
14.40%
ROE (Latest)
10.30%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at PLN 12.91 MM
RAW MATERIAL COST(Y)
Fallen by -8.78% (YoY
NET PROFIT(9M)
Higher at PLN 4.8 MM
CASH AND EQV(HY)
Highest at PLN 17.43 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 36.61 %
NET SALES(Q)
Highest at PLN 30.81 MM
-2What is not working for the Company
ROCE(HY)
Lowest at 10.5%
Here's what is working for Biogened SA
Operating Cash Flow
Highest at PLN 12.91 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (PLN MM)
Net Sales
Highest at PLN 30.81 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (PLN MM)
Cash and Eqv
Highest at PLN 17.43 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 36.61 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Profit
Higher at PLN 4.8 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (PLN MM)
Raw Material Cost
Fallen by -8.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
